Status:
COMPLETED
Effects of Nicorandil on Angina Symptoms in Patients With Coronary Slow Flow
Lead Sponsor:
Mashhad University of Medical Sciences
Conditions:
Slow Coronary Flow
Normal, or Near Normal Coronary Angiography
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Slow coronary flow is an angiographically diagnosed phenomenon defined as delayed opacification of epicardial arteries in the absence of significant arterial narrowing and blockade. Endothelial dysfun...
Eligibility Criteria
Inclusion
- on coronary angiographic studies, arterial narrowing did not exceed 50% in any of the three main coronary arteries; (
- a delayed opacification in at least one of the main coronary arteries was documented. Delayed opacification was defines as corrected TIMI frame count \> 23 fps
Exclusion
- comorbid cardiovascular condition other than mild coronary atherosclerosis and coronary slow flow
- refusal to participate
- discontinuation of treatment
- not returning for the follow up visit
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT02254252
Start Date
March 1 2012
End Date
June 1 2013
Last Update
March 31 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.